Dienogest for Endometriosis
Dienogest, a progestin, has potential as a therapy for patients with endometriosis.
Key Points Lay Summary
Endometriosis and Ovarian Cancer Risk
Ovarian cancer prevalence in women with endometriosis is higher than the general population.
Key Points Lay Summary
The Potential Molecular Mechanisms that Drive Endometriosis Progression
MiR-33b expression and its subsequent impact on the activity of related factors can potentially lead to endometriosis.
Key Points Lay Summary
Special considerations for the evaluation of Endometriosis on MRI
The role of MRI on the evaluation and diagnosis of Endometriotic lesions
Key Points Lay Summary
Plant Compound May Protect Against Endometriosis
The compound called marrubiin is derived from the white horehound in the mint family
Key Points Lay Summary
DNA methylation changes in endometrium during the transition from pre-receptive to receptive phase
Endometrium DNA methylation landscape
Key Points Lay Summary
Factors that Impact IVF-ICSI Outcomes of live birth
Cumulative live birth rate in women with stage III or stage IV endometriosis who have undergone IVF-ICSI can depend on a variety of factors, some that are controllable and some that are not.
Key Points Lay Summary
Women with Deep Infiltrating Endometriosis Have a Higher Risk of Appendix Involvement
Endometriosis of the appendix is a known cause of infertility
Key Points Lay Summary